Veulemans, V.; Hellhammer, K.; Borhan Azad, A.; Goh, S.; Drake, C.; Maier, O.; Piayda, K.; Polzin, A.; Mehdiani, A.; Jung, C.;
et al. Short- and Mid-Term Outcomes in Patients Deemed Inoperable Undergoing Transapical and Transfemoral TAVR with an STS-PROM below Four Percent. J. Clin. Med. 2021, 10, 2993.
https://doi.org/10.3390/jcm10132993
AMA Style
Veulemans V, Hellhammer K, Borhan Azad A, Goh S, Drake C, Maier O, Piayda K, Polzin A, Mehdiani A, Jung C,
et al. Short- and Mid-Term Outcomes in Patients Deemed Inoperable Undergoing Transapical and Transfemoral TAVR with an STS-PROM below Four Percent. Journal of Clinical Medicine. 2021; 10(13):2993.
https://doi.org/10.3390/jcm10132993
Chicago/Turabian Style
Veulemans, Verena, Katharina Hellhammer, Armin Borhan Azad, Shouheng Goh, Christian Drake, Oliver Maier, Kerstin Piayda, Amin Polzin, Arash Mehdiani, Christian Jung,
and et al. 2021. "Short- and Mid-Term Outcomes in Patients Deemed Inoperable Undergoing Transapical and Transfemoral TAVR with an STS-PROM below Four Percent" Journal of Clinical Medicine 10, no. 13: 2993.
https://doi.org/10.3390/jcm10132993
APA Style
Veulemans, V., Hellhammer, K., Borhan Azad, A., Goh, S., Drake, C., Maier, O., Piayda, K., Polzin, A., Mehdiani, A., Jung, C., Westenfeld, R., Kelm, M., Lichtenberg, A., & Zeus, T.
(2021). Short- and Mid-Term Outcomes in Patients Deemed Inoperable Undergoing Transapical and Transfemoral TAVR with an STS-PROM below Four Percent. Journal of Clinical Medicine, 10(13), 2993.
https://doi.org/10.3390/jcm10132993
